ITT - Viracta Therapeutics reports positive results from stage 1 of phase 2 trial for lymphoma treatment April, 15 2024 08:40 AM ITT Inc. 2024-04-15 08:40:27 ET More on Viracta Therapeutics Seeking Alpha’s Quant Rating on Viracta Therapeutics Historical earnings data for Viracta Therapeutics Financial information for Viracta Therapeutics For further details see: Viracta Therapeutics reports positive results from stage 1 of phase 2 trial for lymphoma treatment